J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from ...

Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data ...

Genmab presents a long-term investment opportunity, but uncertainties around Darzalex's pending patent expiration warrant a ...

Japan’s biopharmaceutical logistics market is propelled by demand for temperature-sensitive advanced therapies, regulatory ...

PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE ... Known as F H AB (Fully Human Albumin-Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and ...

Keeping that in mind, LogiPharma Europe wanted to find ways to remedy that challenge, and welcomed a panel discussion on “Future-Proofing for Complex Novel Modalities: How Can You Deliver Personalized ...

The theory behind antibody drug conjugates (ADCs ... 2022, 40, 1255-1263. Norsworthy, K. J., et al. FDA approval summary: mylotarg for treatment of patients with relapsed or refractory CD33 ...

The Next-Generation Biomanufacturing market, valued at USD 25.10 billion in 2024, is expected to register robust revenue CAGR of 10.2%.Request free copy of this report: April, 2025 - Rising demand ...

OpenTexttm , , today introduced the availability of Project Titanium X, now ready with Cloud Editions 25.2 (CE 25.2), the ...

Now a research group led by Heini Ijäs, Maximilian J. Urban, and Tim Liedl from LMU Munich has managed ... cardiac troponin I ...